RNA-binding molecules, such as antisense oligonucleotides and small molecules, facilitate back-splicing progression and augment circular RNA
Therapeutic target molecules and antisense oligonucleic acid (ASO) therapeutic agents for autosomal dominant polycystic kidney disease (ADPKD).
Peptide linker enhances the interaction between VH-VL within scFv molecules, which suppresses intermolecular association.
A novel therapeutic approach for systemic anti-tumor immunity utilizing apolipoproteins
Nucleic acid drug that suppresses aggregate formation through regulation of α-synuclein (αSyn) gene expression.
Discovery of Induction Method from Dental Pulp Cells to Odontoblasts
Caproic acid, a product of anaerobic bacteria identified by elucidating the mechanism of the soil reduction disinfection method, kills pathogens.
Chiral Eu(III) complex combined with DNA-CTMA improves circularly polarized light emission properties.
ASO-4733: Optimized Anti-SYT13 antisense oligonucleotides